Chemokines – role in inflammatory and cancer diseases

Author:

Cisoń-Jurek Sylwia1,Czajka-Francuz Paulina1,Francuz Tomasz1,Wojnar Jerzy1

Affiliation:

1. Klinika Chorób Wewnętrznych i Chemioterapii Onkologicznej, Śląski Uniwersytet Medyczny, Katowice, Polska

Abstract

Over 50 human chemokines are known at present; the number of the newly discovered compounds from this group still grows. These proteins of low molecular weight, belonging to the family of cytokines with chemotactic properties. Chemokines participate in the physiological and pathological processes of the organism. Recent papers show their role in the processes of embryogenesis, organogenesis, allergies, wound healing, angiogenesis and apoptosis, the course of viral and bacterial infections, autoimmune diseases and cancerogenesis. Chemokines play crucial role in activation and migration of immune cells. Being a key player in chronic inflammation, chemokines may interfere the processes of cellular differentiation and contribute to loss of control over proliferation. Coexistence of inflammatory and cancerogenesis processes, impact of chemokines on cells associated with the tumor and stromal cells, mechanisms of immunological escape is considered to be a current scientific issue. Newly discovered functions of chemokines may reveal their new roles and create the new therapeutic perspectives. It is important to understand the relationship between the structure and function of chemokine receptors, the regulation of their signaling pathways and the genetic and epigenetic mechanisms that regulate the expression of chemokines and their receptors. This article presents the current state of knowledge regarding the construction and classification of chemokines and summarizes the most prominent roles of chemokines. Chemokines are still the subject of many scientific studies, new functions are being discovered. It gives an opportunity to limit the development of many dangerous diseases.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Reference91 articles.

1. Agesen T.H., Sveen A., Merok M.A., Lind G.E., Nesbakken A., SkotheimR.I., Lothe R.A.: ColoGuideEx: A robust gene classifier specificfor stage II colorectal cancer prognosis. Gut, 2012; 61: 1560–7

2. Akishima-Fukasawa Y., Nakanishi Y., Ino Y., Moriya Y., KanaiY., Hirohashi S.: Prognostic significance of CXCL12 expression inpatients with colorectal carcinoma. Am. J. Clin. Pathol., 2009; 132:202–10

3. Alberts B., Johnson A., Lewis J., Morgan D., Raff M., Roberts K.,Walter K.: Molecular Biology of the Cell. Garland Science, NewYork 2015, 814–9

4. Alon R., Chen S., Fuhlbrigge R., Puri K.D., Springer T.A.: Thekinetics and shear threshold of transient and rolling interactionsof L-selectin with its ligand on leukocytes. Proc. Natl. Acad. Sci.USA, 1998; 95: 11631–6

5. Bachelerie F., Ben-Baruch A., Burkhardt A.M., Combadiere C.,Farber J.M., Graham G.J., Horuk R., Sparre-Ulrich A.H., Locati M.,Luster A.D., Mantovani A., Matsushima K., Murphy P.M., NibbsR., Nomiyama H. i wsp.: International Union of Basic and ClinicalPharmacology. LXXXIX. Update on the extended family of chemokinereceptors and introducing a new nomenclature for atypicalchemokine receptors. Pharmacol Rev., 2014; 66: 1–79

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3